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KAJIAN PENGLIBATAN WIF-1 DALAM ORAL KARSINOGENESIS 
MELALUI LALUAN ISYARAT EGFR DAN WNT 
 
ABSTRAK 
 
Faktor perencat WNT 1 (WIF-1) adalah perencat fisiologi dalam laluan isyarat WNT 
melalui domain WIF. Fungsi domain serupa EGF dalam WIF-1 masih perlu dikaji. 
Kajian terbaru menunjukkan peningkatan ekspresi WIF-1 dalam sel kanser yang 
progresif, satu fenomena yang bercanggah dengan mekanisme isyarat sel dalam 
perkembangan sel kanser. Kajian ini bertujuan untuk menjelaskan potensi pengikatan 
WIF-1 dengan EGFR, yang memulakan laluan isyarat EGFR kaskade dan/atau 
melalui cakap silang antara EGFR dan laluan isyarat hiliran WNT, yang akhirnya 
menyebabkan pembentukan kanser. Kajian dimulakan dengan analisis dok protein-
protein antara WIF-1 dan molekul EGFR menggunakan pelayan talian CAPRI-
tersenarai, iaitu ZDOCK, Gramm-X, HEX dan PatchDock. Pengimunomendakan 
bersama dan pemendapan Western telah direka untuk mengkaji pengikatan EGFR / 
WIF-1 dan penghasilan pengaktifan potensi bagi laluan isyarat EGFR dan WNT 
akibat pengikatan tersebut. Sel mutan yang stabil telah ditubuhkan untuk mengkaji 
cakap silang antara laluan isyarat WNT dengan EGFR. Ekspresi gen hiliran telah 
dilakukan menggunakan PCR masa nyata. Keputusan eksperimen mencadangkan 
bahawa WIF-1 boleh memainkan peranan tambahan dalam laluan isyarat EGFR 
melalui domain EGF-like. Pengikatan in siliko bagi WIF-1 kepada EGFR adalah 
berdaya sesuai (-616,40 kcal / mol), berbanding dengan pengikatan EGF/EGFR (-
627,18 kcal / mol). Dalam pengimunomendakan bersama, WIF-1 telah terikat kepada, 
dan seterusnya pengimunomendakan bersama dengan, EGFR. Faktor utama dalam 
xxii 
 
hiliran bagi laluan isyarat EGFR didapati diaktifkan berikut pengikatan WIF-1 
kepada EGFR. Selain itu, keputusan yang diperolehi menunjukkan pengaktifan 
penting bagi hiliran, tetapi bukan huluan, laluan isyarat WNT kaskade melalui cakap 
silang dari pengaktifan laluan isyarat EGFR oleh WIF-1. Pendek kata, data kami 
jelas menunjukkan bahawa WIF-1 mungkin memainkan peranan yang berbeza dalam 
pembentukan kanser dengan berinteraksi dengan EGFR, selain daripada bertindak 
sebagai ahli antagonis bagi WNT. Oleh itu, kajian semula adalah untuk mengkaji 
kesesuaian WIF-1 sebagai agen anti-kanser. 
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STUDY ON THE INVOLVEMENT OF WIF-1 IN ORAL CARCINOGENESIS 
VIA EGFR AND WNT SIGNALING PATHWAYS 
 
ABSTRACT 
 
WNT inhibitory factor 1 (WIF-1) is a physiological inhibitor in WNT signaling 
pathway via its WIF domain. The function of EGF-like domain in WIF-1 remains 
unclear. Recent studies had indicated an increase in WIF-1 expression in progressive 
cancer cells, a phenomenon contradicting to the known cell signaling mechanisms in 
cancer cell progression. The present study aimed at elucidating the potential binding 
of WIF-1 to EGFR, leading to initiation of EGFR downstream signaling cascades 
and/or via the crosstalk between EGFR and downstream of WNT signaling pathways, 
which ultimately resulting in cancer formation. Initial protein-protein docking 
between WIF-1 and EGFR molecules was performed using CAPRI-listed online 
servers, namely ZDOCK, GRAMM-X, HEX and PatchDock. Co-
immunoprecipitation and Western blot were designed to study the binding of 
EGFR/WIF-1 and the potential activation of EGFR and WNT downstream signaling 
pathways resulting upon the binding. Stable mutant cell lines were established to 
study the crosstalk between WNT and EGFR signaling pathways. Downstream gene 
expression initiated by the crosstalk was investigated using quantitative real-time 
PCR. The experimental results suggested that WIF-1 could play additional role in 
EGFR signaling pathway via its EGF-like domain. In silico binding of WIF-1 to 
EGFR was energetically favorable (-616.40 kcal/mol), as compared to EGF/EGFR 
binding (-627.18 kcal/mol). In co-immunoprecipitation, WIF-1 was bound to, and 
hence was co-immunoprecipitated with, EGFR. Downstream key factors in EGFR 
xxiv 
 
signaling pathway were found to be activated following the binding of WIF-1 to 
EGFR. Moreover, the results obtained showed a prominent activation of downstream, 
but not of upstream, cascades of WNT signaling pathway via crosstalk from WIF-1 
activated EGFR signaling pathway. In short, the data obtained have clearly shown 
that WIF-1 might play a different role in cancer formation by interacting with EGFR, 
rather than acting as an antagonist of WNT members. It is therefore crucial to review 
the appropriateness of WIF-1 to be used as an anti-cancer agent in the field. 
 
 
1 
 
CHAPTER 1: INTRODUCTION 
 
Cancer is one of the most common causes of morbidity and mortality today, with 
more than 14 million new cases and more than 8.2 million deaths each year globally 
(Stewart and Wild, 2014). In head and neck cancers, over 90% are oral squamous 
cell carcinomas (OSCC). OSCC is one of the top ten cancers worldwide, with broad 
differences in geographic distribution. It affects at least 0.3 million people annually 
worldwide. This disease claims the lives of almost 70,000 people each year or about 
eight persons every hour (Stewart and Wild, 2014). In South-East Asia especially in 
developing country like India, the challenges of OSCC burden may increase over 75% 
of cancer deaths in 2020, as compared to 2000 (Mishra and Meherotra, 2014). The 
major risk factors that contribute to OSCC development are tobacco use and alcohol 
consumption (ACS, 2014). Synergistic effects of smoking and alcohol may increase 
the risk for OSCC development by 30-fold (ACS, 2014). Betel quid chewing is a 
lifestyle behavior in as high as 40% of adult population (Petti et al., 2013).  
 OSCC is normally preceded from oral precancerous lesion, particularly 
leukoplakia and erythroplakia. Oral leukoplakia is the most common type of oral 
precancerous lesions detected in the early stage of OSCC development. It is a white 
plaque in oral mucosa which is hardly characterized clinically or pathologically. The 
risk of malignancy transformation of patients with oral leukoplakia is 8 to 10 times 
higher than those who do not. Oral leukplakia may bypass dysplasia stage and 
directly enter into metaplasia stage, subsequently developed into invasive carcinoma 
(Wang et al., 2009). Other type of oral precancerous lesion is oral erythroplakia. It is 
a velvety red plaque that is rarely found in the oral mucosa. As compared to 
2 
 
leukoplakia, erythroplakia is 17 times more prominent in developing severe dysplasia 
in at least 85% of OSCC cases (Scully et al., 2008).  
On a related note, OSCC surgery can be very disfiguring and thus 
psychologically traumatic in a society that places a high value on physical 
appearance. Treatment of this condition often results in severe loss of oral function, 
and chronic discomfort including difficulty in chewing, swallowing, and speaking. 
With the advancement in diagnosis and treatment, the average 5-year survival rate 
for OSCC is about 62% (ACS, 2014). Early detection of OSCC increases the chance 
that a person lives 5 years after initial diagnosis; the 5-year survival rate is 81% for 
those diagnosed with early-stage OSCC but only 22% for persons diagnosed with 
advanced stage cancer. Only 35% of OSCC is detected at the earliest stage (CDC, 
2000). However, the prognosis of OSCC is still unsatisfying, including delayed 
precancerous lesion detection, increased rate of relapse and lymph node metastases 
(Chang et al., 2007; Zhang et al., 2012). Hence, OSCC is a significant component of 
the global burden of cancer and better understanding in oral carcinogenesis is needed 
to improve the survival rate of patients. 
The missing link between inflammation and oral carcinogenesis in molecular 
signaling pathway is not clear at present time. As early as 1863, Rudolph Virchow 
already proposed that cancers tended to occur at sites of chronic inflammation 
(Balkwill and Mantovani, 2001). Lately, tumor-promoting inflammation has been 
listed as one of the important hallmarks in carcinogenesis (Hanahan and Weinberg, 
2011). This is because multiple hallmarks functions can be promoted by 
inflammatory-induced microenvironment. A general paradigm model for human 
carcinogenesis is often viewed as a multi-stage disease due to the accumulation of 
tumor suppressor genes and oncogenes in the cell (Luu et al. 2004). The activity of 
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key players involved in those cancer cell signaling pathways may serve as an 
alternative cancer treatment for current cancer therapy. Due to the early involvement 
in cell development, the interaction between epidermal growth factor receptor 
(EGFR) and wingless and integration site growth factor (WNT) signaling pathways 
are highly focused in clinical research (Musgrove, 2004; Tan et al., 2005; Shclange 
et al., 2007; Suzuki et al., 2007a; Taylor et al., 2007) 
 From the cell signaling point of view, those important factors i.e. cigarette 
smoking and alcohol will lead to EGFR overexpression in 90% of OSCC cases and 
further cascade of cell signaling may facilitate OSCC development. Given the 
potential of WNT inhibitory factor 1 (WIF-1) to be used as natural inhibitor of WNT 
signaling pathway to prevent carcinogenesis and/or the progression of cancer 
resulted from the activity of WNT signaling pathway, it is crucial to ensure that WIF-
1 would not contribute to any unwanted negative effects in the potential cancer-
inhibition function. Interestingly, WIF-1 is made up of WIF domain and 5 repeated 
EGF-like domains whereby EGF is one of the ligands that specifically bind to EGFR. 
Hence, there may be a possibility that WIF-1 might bind to the oral squamous cells at 
the upstream of cell signaling pathway, playing a similar role as EGF and at the same 
time, it may bind to the WNT molecule at the downstream of cell signaling pathway 
as its ordinary role. Such a combination may fool the oral cells in response to the cell 
signaling. Nevertheless, contradictions were found in many cases wherein the 
expression of WIF-1 was increased with cancer formation (Suzuki et al. 2007a; 
Suzuki et al. 2007b). This type of observations implies that WIF-1 might play a 
cancer-promoting role via other mechanism(s) in addition to its endogenous 
inhibitory property in WNT signaling pathway. Thus, experiment designed in this 
4 
 
project is to investigate the possible role for WIF-1 in oral carcinogenesis. The 
hypothesized mechanisms of WIF-1 in oral carcinogenesis are shown in Figure 1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Possible role of WIF-1 in oral carcinogenesis. WIF-1 is a physiological 
inhibitor in WNT signaling pathway.  With the presence of WIF-1, it will bind to 
WNT directly and prevent WNT-mediated oral carcinogenesis. However, if WIF-1 is 
interacting with EGFR, the downstream of EGFR signaling pathways (such as AKT) 
could be activated. Crosstalk between WNT and EGFR signaling pathways may be 
happened and result in oral carcinogenesis (Hu and Li, 2010; Bányai et al., 2012) 
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1.1 Objectives 
1. To investigate the binding between WIF-1 and EGFR 
2. To examine the potential cell signaling factors involved in oral 
carcinogenesis at gene expression level and at protein level. 
3. To study the crosstalk between WNT and EGFR signaling pathways in oral 
carcinogenesis  
4. To examine the downstream mechanism(s) involved in these signaling 
pathways to assess the newly proposed model implicated in oral 
carcinogenesis 
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Figure 1.2: Flow chart of Research. For further explanation, please refers to Section 3.1. 
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CHAPTER 2: LITERATURE REVIEWS 
 
2.1 Oral cancer  
 
2.1.1 Background 
According to World Cancer Report 2014 (Stewart and Wild, 2014), the global 
burden of cancer in 2012 has rose an estimated 14 million new cases per year and 
this figure is expected to increase to 22 million annually in next 20 years. Globally, 
cancer has accounted for at least 8.2 million deaths in 2012. In head and neck cancers, 
over 90% are squamous cell carcinomas (SCC) which are commonly found in the 
oral cavity. Oral squamous cell carcinomas (OSCC) consistently rank as one of the 
top ten cancers worldwide, with broad differences in geographic distribution.  
 In United States, oral cancer affects approximately 42000 people with an 
estimated 8390 death cases in 2014 (ACS, 2014). The rates of incidence are more 
than twice as high in male as in female. In Europe, OSCC accounted for 61416 new 
cases in 2012 with a mortality rate of 1.3% (Stewart and Wild, 2014). The incidence 
rate of males is double the rate of that in female. However, OSCC cases are much 
more serious in Asia region, with 0.1 million new cases and more than 50% mortality 
rate, especially in male (Stewart and Wild, 2014). Almost one-third of global cases 
and half of worldwide deaths from OSCC occur in this region. In Malaysia, OSCC is 
ranked at the fourteenth most common cancer, accounting for 2.1% of incidence rate 
for both genders and leads to 1.2% of mortality rate in total cancer cases (Stewart 
and Wild, 2014). The 5-year prevalence for adult population to develop OSCC in 
Malaysia is about 2.2%. In males, it is the tenth most common cancer, while it is 
thirteenth in females.   
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2.1.2 Inducing factors in oral carcinogenesis  
Oral squamous cell carcinoma (OSCC) is a multifactorial development, influenced 
by genetic abnormalities and lifestyle behaviours. As reviewed by Stefano Petti 
(2009) and Jukka H. Meurman (2010), oral cancers are associated with cigarette 
smoking, alcohol consumption, betel quid chewing, poor oral hygiene and infection. 
However, the detailed mechanisms involved are yet to be explored.  
 
2.1.2.1 Cigarette smoking 
Tobacco usage in various forms has known to be a major risk factor for oral 
carcinogenesis (Figure 2.1). The International Agency for Research on Cancer 
(IARC) (2004) suggested that there is more than 60 carcinogens in each puff of 
cigaratte smoke. Though the direct mechanism of smoking to oral cancer is still 
unclear, it was believed that polycyclic aromatic hydrocarbons (PAHs) and N-
nitrosamines may induce DNA damage, promote gene methylation and mutation, and 
cause chromosomal aberrations in target organs (Toh et al., 2010). Cigarette smoke 
also contains free radicals in either tar phase or gas phase which is capable of 
promoting oxidative damage (Pasupathi et al., 2009). However, the role of oxidative 
damage in causing oral cancers remains to be explored. 
According to the surgeon report in U.S. Department of Health and Human 
Services (USDHHS) (2010), most genotoxic agents in cigarette smoke are 
metabolically activated by cytochrome P450 enzyme and then covalently bind to 
DNA to produce DNA adducts. The persistent DNA adducts can cause miscoding 
during DNA replication and lead to mutation in critical genes such as KRAS 
oncogenes and TP53 tumor-suppressor genes. Some of the genotoxic agents may 
react with DNA directly to form DNA adducts without the process of metabolic  
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Figure 2.1: Schematic presentation of compounds in cigarette smoke and their roles 
in carcinogenesis. Cigarette smoke contains more than 60 carcinogens. Polycyclic 
aromatic hydrocarbons (PAH) and N-nitrosamine are metabolically activated by 
cytochrome P450 enzyme and form DNA adduct which later induce DNA damage, 
gene mutations and finally leads to carcinogenesis. The balance between the 
metabolic activation of carcinogens and detoxification were catalysed by glutathione-
S-transferases (GST), uridine-5’-diphosphate-glucuronosyltransferases (UDP-GT) 
and etc. Nicotine may up-regulating the gene expression level of AKT, epidermal 
growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) and promotes 
angiogenesis which then lead to carcinogenesis. Free radicals in the cigarette smole 
may induce DNA damage while other genotoxic compounds promote DNA 
methylation of oncogenes and increase the expression of tumor-suppressor genes for 
carcinogenesis (Figure from Toh et al., 2010) 
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activation. The formation of DNA adduct is normally at the adenine or guanine sites 
and lead to the initiation of carcinogenesis (Chen et al., 2011). The balance between 
the metabolic activation of carcinogens and detoxification were catalyzed by 
numerous enzymes, including glutathione-S-transferases (GSTs), uridine-5’-
diphosphate-glucuronosyltransferases (UDP-GTs), epoxide hydrolases, and 
sulfatases varies among individuals and is likely to affect cancer susceptibility 
(Stadler et al., 2008). Moreover, nicotine may be involved in the initiation and 
invasion of tumors via AKT pathway (Xu et al., 2007). Nicotine mimicking the mode 
of action of cellular growth factors and modulates their biological mechanism 
through the activation of nicotinic acetylcholine receptors, β-adrenoceptors or 
epidermal growth factor receptor (EGFR) (Chen et al., 2011). However, the roles of 
these receptors are cell-type dependent.   
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2.1.2.2 Alcohol consumption 
Pure ethanol is not a direct carcinogen and can be metabolized by alcohol 
dehydrogenase (ADH) in the liver to form acetaldehyde (Figure 2.2). Acetaldehyde 
is carcinogenic and able to induce gene mutations through the formation of DNA 
adducts (Morse et al., 2007; Toh et al., 2010). Such actions may interfere with DNA 
synthesis and repair. However, the amount of acetaldehyde present in various tissues 
may also depend on the polymorphism of alcohol-metabolizing enzymes, i.e. ADH 
and aldehyde dehydrogenase (ALDH). For example, epidemiological studies 
demonstrated that individuals with heterozygous inactive ALDH2*2 genotype are 
still able to oxidize acetaldehyde to acetate with a markedly reduced activity.  
Following alcohol consumption, these individuals may generate 3-fold higher 
concentrations of acetaldehyde in serum and saliva as compared to individuals with 
normal homozygosity of ALDH2*1 genetic background (Seitz and Stickel, 2007; 
Yokoyama et al., 2007). Ethanol can be oxidized to acetaldehyde by normal oral 
microflora. However, there is limited further metabolism of acetaldehyde to acetate 
by oral bacteria, hence the salivary acetaldehyde concentration can be accumulated 
up to 10- to 100-fold higher than that in the blood (Homann et al., 2000).  
 In addition to that, ethanol can also be oxidized by cytochrome P450 2E1 
(CYP2E1)-dependent microsomal monooxygenase system. Ethanol-mediated 
reactive oxygen species (ROS) are generated during alcohol metabolism by CYP2E1 
(Seitz and Becker, 2007). Chronic ethanol consumption in animals and humans lead 
to marked induction of hepatic CYP2E1 enzyme by 10- to 20-fold as compared to 
non-chronic ethanol consumers. Those ethanol-mediated ROS produced by CYP2E1 
may result in oxidative injury, inflammation, and lipid peroxidation (Seitz and 
Stickel, 2007). Therefore, the oxidative stress caused by ROS is suggested as a  
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Figure 2.2: Schematic presentation of ethanol metabolism and its role in 
carcinogenesis. Ethanol is metabolized to acetaldehyde by alcohol dehydrogenase 
(ADH) and cytochrome P450 2E1 (CYP2E1), which is then further oxidized to 
acetate by acetaldehyde dehydrogenase (ALDH). ADH-mediated ethanol metabolism 
results in reduced nicotinamide adenine dinucleotide (NADH) and acetaldehyde, 
whereas ethanol oxidation by CYP2E1 leads to the production of acetaldehyde and 
reactive oxygen species (ROS). The amount of acetaldehyde present may also 
depends on the polymorphisms of alcohol-metabolizing enzyme, i.e. CYP2E1, 
ALDH and alcohol dehydrogenase (ADH). Increased CYP2E1 activity not only leads 
to increased generation of ROS, but also to an increased activation of various 
environmental pro-carcinogens present in tobacco smoke and certain diets. CYP2E1 
also decreases tissue levels of retinol and retinoic acid, which have important 
functions in the regulation of cell growth and transdifferentiation. NADH is 
reoxidized to NAD
+
 in the mitochondria, which may further increase the generation 
of ROS. The increased levels of acetaldehyde and ROS may lead to DNA adduct 
formation (Figure from Seitz and Stickel, 2007) 
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critical pathophysiological mechanism in various human diseases, including cancer. 
Interestingly, some literature reviews suggested an association between alcohol-
containing mouthwashes and oral cancer development (McCullough and Farah, 2008; 
Vecchia, 2009). However, the epidemiological findings are not consistent across 
various studies. 
 
2.1.2.3 Synergistic effects between cigarette smoking and alcohol consumption 
Cigarette smoking and alcohol consumption is known to be associated with oral 
carcinogenesis either independently or synergistically in a dose-dependent fashion 
(Morse et al., 2007; Ganci et al., 2012). Simultaneous exposure to smoking and 
drinking may increase oral cancer risk by 2- to 4-fold, as compared to independent 
exposure to either of the risk factors (Castellsagué et al., 2004). Furthermore, alcohol 
may act as a natural solvent for tobacco carcinogens, enhancing and prolonging the 
mucosal exposure of tobacco carcinogens to target tissues (Mehrotra and Yadav, 
2006; Ganci et al., 2012). In addition, cigarette smoking is found to double up the 
salivary acetaldehyde level by altering the oral microflora and thereby increase the 
bacterial ADH activity (Salaspuro and Salaspuro, 2004; Seitz and Stickel, 2007). 
Smoking may rapidly shift the oral microflora from Gram-negative to Gram-positive 
bacteria as Gram-positive bacteria able to produce high amounts of acetaldehyde as 
compared to Gram-negative bacteria (Salaspuro, 2003). 
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2.1.2.4 Betel quid and areca nut extract 
Betel quid chewing is a common traditional or social practice that link to oral 
leukoplakia and oral submucous fibrosis in a dose-dependent manner (Sharan et al., 
2012). Areca nut, also known as betel nut, can be consumed alone or combined with 
others additives and wrapped in a betel leaf as betel quid. The alkaloids extracted 
from betel quid can give stimulant sensation to betel quid chewers and increase their 
work capacity with higher alertness (Petti, 2009). The components of betel quid may 
vary among countries, regions, communities and individuals. In India, heavy betel 
quid chewer will add tobacco as an additive but such preparation is not being 
practiced in Papua New Guinea and China (Sharan et al., 2012). With the addition of 
tobacco in betel quid, the risk of oral precancerous development will be increased by 
3-fold (Stadler et al., 2008; Petti et al., 2013).  
 During the chewing process of betel quid, ROS may be produced in the oral 
cavity due to the auto-oxidation of areca nut polyphenols under the alkaline 
condition enhanced by slaked lime (Adhikari and De, 2013). Such ROS formation 
causes detrimental effects to oral mucosa by inducing mutation and genotoxicity in 
relation to tumor initiation process. Besides that, ROS can also change the structure 
of oral mucosal to be more susceptible to the penetration of other betel quid 
components and environmental toxicants (Mehrotra and Yadav, 2006). Moreover, 
the endogenous nitrosation of areca nut may potentially generate carcinogenic 
nitrosamines (Petti, 2009). Areca nut-specific nitrosoamines may interact with DNA, 
proteins or other targets to form adducts and exerting its carcinogenic activities 
(Adhikari and De, 2013). In short, areca nut and/or betel quid mastication is 
significantly associated with oral cancer formation. 
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2.1.2.5 Infectious agents – bacterial, yeast and viral infection 
Oral cavity has constantly exposed to a huge diversity of microorganisms. It is 
estimated that about 15 to 20% of oral cancer with not known risk factors are related 
to microbial infection and inflammation (Mager, 2006; Chocolatewala et al., 2010; 
Meurman, 2010). A shift of the microbial patterns in the oral cavity may be due to 
smoking, alcohol consumption, betel quid chewing and poor oral hygiene (Hooper et 
al., 2009). Interestingly, many microbial species found to be related to cancer 
development are highly site-specific but their roles in cancer formation are still 
unclear (Hooper et al., 2009). Proposed mechanism for microbial infection to initiate 
cancer formation can be either through chronic inflammation and disruption of 
eukaryotic cell cycle and signaling pathways, or by metabolism of carcinogenic 
products such as acetaldehyde (Chocolatewala et al., 2010).  Hence, the possible 
relationship between microorganisms and carcinogenesis becomes an interesting 
matter to be concerned. 
  
2.1.2.5.1 Bacterial infection 
Alteration of the oral microbiota in oral cancer is an essential biomarker to identify 
specific microorganisms that prevail in tumor specimen. Interestingly, a diversity of 
bacteria species was isolated from the microflora population of tumourous site and 
control sites (Meurman, 2010). Most of the isolated bacteria are saccharolytic and 
acid tolerant. This characteristic enables them to survive in the hypoxic and acidic 
solid tumor environment. Significant salivary analysis also noted that some bacteria 
species are specifically detected in the saliva of oral cancer patients, but may not be 
detected in the tumor site (Chocolatewala et al., 2010).  Bacterial agents may induce 
carcinogenesis through chronic infection or toxin production that interferes with 
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cellular signaling mechanisms. They may also act as tumor promoter, promote 
cellular proliferation, inhibit apoptosis and help in immune evasion (Mager, 2006). 
Moreover, the production of salivary acetaldehyde from alcohol metabolism by oral 
bacteria also explained another additional mechanism in the bacteria–oral 
carcinogenesis interaction (Meurman and Uittamo, 2008). In short, the carcinogenic 
mechanism by bacterial infection is not clear, but it was believed that the detected 
oral bacteria is site-specific and may play a different role in oral carcinogenic process. 
 
2.1.2.5.2 Fungal infection 
Candida albican is one of normal flora in oral cavity. Overgrowth of it is associated 
with poor oral hygiene and periodontitis. Chronic hyperplastic candidosis is a rare 
oral fungal infection (Chocolatewala et al., 2010). The invasion of candidal hyphae 
into oral epithelium may lead to oral leukoplakia and dysplastic changes. Candidal 
leukoplakias appear to be a more aggressive type in oral carcinoma transformation as 
compared to other types (Hooper et al., 2009). About 9 to 40% of the candidal 
leukoplakia cases are estimated to develop into oral carcinoma (Meurman, 2010). 
Animal studies have confirmed that long-term candidal infection may result in 
malignant transformation in oral mucosa (Hooper et al., 2009). Candida may induce 
malignant transformation by generating nitrosamine compounds as proto-oncogene 
activators (Hooper et al., 2009) or synergistically associated with other risk factors 
such as tobacco smoking and alcohol consumption (Meurman, 2010). However, there 
are no studies demonstrate that a control of Candida would reduce the incidence of 
oral cancer. 
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2.1.2.5.3 Viral infection 
Without the correlation with smoking and alcohol consumption, human 
papillomavirus (especially HPV-16 and 18) infection alone has contributing to about 
70% of oral and oropharyngeal carcinomas (Ganci et al., 2012). However, HPV 
infection may show a latency period in 12% of subjects with clinically healthy oral 
mucosa (Meurman, 2010). The repeated viral exposure may be due to certain sexual 
practices. The expression of viral proteins disrupted the cell cycle regulation, 
promote cell growth and increase the frequency of gene mutation and chromosomal 
instability (Chung and Gillison, 2009). In addition, herpes virus (HSV) (Shillitoe, 
2009) and human immunodeficiency virus (HIV) (Epstein et al., 2005) are also 
reported to correlate with oral carcinogenesis with the presence of common risk 
factors such as smoking and alcohol consumption. Therefore, more data is needed for 
further conclusion. 
 
2.1.3 Role of inflammation in oral cancer 
The link between inflammation and oral carcinogenesis in molecular signaling 
pathway is still not clear at present time. As early as 1863, Rudolf Virchow had 
proposed the role of chronic inflammation in carcinogenesis (Balkwill & Mantovani, 
2001). One way to describe the process linking inflammation to cancer is through the 
illustration of essential “hallmarks” in cancer formation (Hanahan and Weinberg, 
2011). Cancer development requires the acquisition of ten fundamental properties: 
self-sufficient proliferation, insensitivity to anti-proliferative signals, escape from 
immune destruction, unlimited replicative potential, tissue invasion and metastasis, 
the maintenance of vascularization, genome instability and mutation, evasion of 
apoptosis, deregulation of cellular energetic and most importantly, tumor-promoting 
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inflammation. Inflammation can foster multiple hallmark functions by providing 
several bioactive molecules to the tumor microenvironment (Hanahan and Weinberg, 
2011).  
Acute inflammation may help in cancer regression but chronic inflammation 
may promote cancer progression (Philip et al., 2004). In oral carcinogenesis, 
epithelial inflammation is also a factor to initiate cancer formation (Hooper et al., 
2009). The use of tobacco, alcohol and betel quid induce the formation of DNA 
adduct and free radicals which may later generate an inflammatory 
microenvironment for genetic alteration and cancer promotion. Besides that, chronic 
inflammation result from chronic microbial infection may also predispose to cancer 
formation (Lu et al., 2006). Inflammation-induced reactive oxygen and nitrogen 
species may directly or indirectly contribute to malignant cell transformation by 
induction of genomic stability and alterations of cellular epigenetic events (Kundu 
and Surh, 2008).  
Cells have intrinsic mechanisms by which to prevent unregulated 
proliferation or the accumulation of DNA mutations. These include tumor suppressor 
pathways that mediate DNA repair, cell cycle arrest, apoptosis and senescence. In the 
effects of DNA damage or oncogenic activation, cells will either repair their DNA to 
prevent mutations or initiated cells will undergo cell death. If massive cell death 
occurred in infection or non-infectious tissue injury, loss of cell population will be 
replaced by the proliferation of neighbouring cells, or undifferentiated precursor cells. 
Many inflammatory pathways function to mediate these tissue repair mechanisms 
(Chen et al., 2003; Wang et al., 2005). In an extension of its physiologic role in 
mediating tissue repair or as a strategy in host defense to infection, the inflammatory 
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response may play a role in providing survival and proliferative signals to initiated 
cells, thereby leading to tumor promotion. 
Direct evidence for a link between carcinogenesis and either host defense and 
tissue repair due to inflammation has yet to be developed as cells are organic 
microsystems with functional compartments interconnected by multiple signal 
pathways (Wolf, 2007). A distinct network of intracellular signaling molecules 
involving protein kinases, membrane receptors and transcription factors are 
interacting together to facilitate carcinogenesis (Kundu and Surh, 2008). To address 
the details of transition from inflammation to cancers and the further development of 
inflammation-associated cancers, it is necessary to investigate specific roles of key 
regulatory molecules in the oral cancer signaling pathways involved. A summary of 
inflammatory mechanisms that lead to cancer development is shown in Figure 2.3. 
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Figure 2.3: Summary of mechanisms for the involvement of inflammation in cancer 
development. Acute inflammation may undergo resolution of inflammation or as a 
factor to initiate cancer formation. Inflammatory-induced free radicals i.e. reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) may directly or indirectly 
induce DNA damage or mutation, and contribute to malignant transformation. The 
inflammatory cells may mediate tissue repair mechanism due to the chronic 
inflammatory response, for cell survival and cell proliferation. The overexpression of 
pro-inflammatory cytokines, chemokines and etc may lead to tumor promotion. 
Hypoxia-induced mechanism will also take part in this inflammatory 
microenvironment which then leads to carcinogenesis. Tumor promotion indicates 
the process during which initiated cells develop into benign lesions. Tumor 
progression defines the process during which benign tumors progress to malignant 
carcinomas (Figure from Lu et al., 2006) 
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2.1.4 Signaling pathways involved in oral cancer 
 
2.1.4.1 EGFR signaling pathway  
Epidermal growth factor receptor (EGFR) protein was reported to be overly 
expressed in almost 90% of head and neck squamous cell carcinoma (HNSCC), 
especially in oral squamous cell carcinoma (OSCC) with poor association of gene 
amplification status (Bernardes et al., 2013; Maiti et al., 2013). Elevated EGFR 
expression happened throughout the premalignant stages of carcinogenesis, ranging 
from dysplastic lesions to OSCC (Mahendra et al., 2014). Besides that, 
overexpression of EGFR is always associated with cancer proliferation and 
metastasis, which may later contribute to poor prognosis and reduced survival rate 
(Kalyankrishna and Grandis, 2006; Ribeiro et al., 2014).  Licitra et al. (2011) also 
reported that post-curative surgical removal of tumor cells in HNSCC patients shows 
an overexpression of EGFR in the normal, metaplastic and dysplastic epithelium, 
surrounding the resected tumor region. Such aberrant expression of EGFR may 
potentially trigger cancer recurrence locoregionally. Activated EGFR may promote 
several EGFR-related pathways such as mitogen-activated protein kinase (MAPK) 
for cell proliferation; AKT for cell survival and anti-apoptosis; signal transducers and 
activators of transcription (STAT) for gene transcriptional activity (Licitra et al., 
2011). Overview of EGFR and its-related pathways will be further discussed in 
Section 2.2. EGFR-targeting therapy especially small molecule tyrosine kniase-
specific inhibitors and monoclonal antibodies showed good anti-cancer effects in 
preclinical HNSCC models when administered alone or in conjugation with 
chemotherapy and/or radiotherapy (Choi and Meyer, 2008; Harari et al., 2009). 
Therefore, EGFR and its-related downstream signaling pathways are aimed to be the 
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hallmark for oral cancer and potential biomarkers or theraupetic candidates for oral 
cancer prognostic and/or survival indicator (Licitra et al., 2011).   
 
2.1.4.2 WNT signaling pathway 
Aberrant activation in WNT/β-catenin signaling pathway promotes abnormal cell 
proliferation, survival, and consequently results in epithelial-to-mesenchymal 
transition (EMT) and the development of epithelial cancers including colon, skin, 
liver, and ovarian cancers (Morin and Weeraratna 2003; Moon et al. 2004; Nelson 
and Nusse 2004; Taketo 2004; Huber et al. 2005; Reya and Clevers 2005; Clevers 
2006; Blanpain et al. 2007; Polakis 2007). Additional mechanisms by which defects 
in the regulation of WNT signaling contribute to tumor progression probably remain 
undiscovered. The manifestation of cancer by aberrant WNT signaling most likely 
results from inappropriate gene activation mediated by stabilized β-catenin or 
epigenetic inactivation of WNT inhibitors. Uraguchi et al. (2004) demonstrated a 
panel of WNT genes expressed in cell type-specific OSCC cell lines and their 
immunohistochemistry results in oral carcinoma tissues showed an association 
between WNT3 expression and nuclear localization of β-catenin in invasive OSCC. 
Several target genes of β-catenin signaling have now been identified and some of 
their functions are consistent with the control of tumor cell growth, differentiation 
and survival (Major et al., 2007). No mutated β-catenin was reported in OSCC (Lo 
Muzio et al., 2005). Surprisingly, Prgomet et al. (2014) showed that elevated 
WNT5A expression in OSCC cell lines may also promote cancer cell invasion and 
migration via noncanonical WNT signaling pathway. Epigenetic alteration i.e. DNA 
methylation of WNT inhibitors contribute to early and late phases of OSCC initiation 
and progression (reviewed by Mascolo et al., 2012). Thus, activation of the WNT 
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signaling pathway can have a significant impact on tumor progression. Overview of 
WNT signaling pathways will be further discussed in Section 2.3. However, WNT 
mechanisms in oral carcinomas are still largely unexplored (Papagerakis and 
Pannone, 2012). 
 
2.1.4.3 NF-κB signaling pathway  
Nuclear factor-κB (NF-κB) is a dimeric nuclear transcription factor that plays a 
major role in immune response, cell adhesion, cell proliferation and differentiation, 
angiogenesis and apoptosis (Sun and Zhang, 2007).  It is also a central dogma that 
responded to all the inflammatory stresses (Sawhney et al., 2007). Dysregulation of 
NF-κB activity is commonly related to inflammatory disease, autoimmune and 
metabolic disorders and also cancer development (Oeckinghaus et al., 2011). In cell, 
NF-κB is retained in the cytoplasm by its inhibitory protein IκB, in the inactivate 
form of NF-κB -IκB complex. In response to extracellular stimuli, IκB is subjected to 
phosphorylation, ubiquitination, and subsequently degraded by the proteasomal 
mechanism via a canonical IκB kinase (IKK) complex-dependent pathway or a 
noncanonical NF-κB -inducing kinase pathway. The degradation of IκB results in 
NF-κB activation. NF-κB then translocates to the nucleus to regulate target gene 
expression that involved in cell fate (Lu et al., 2006; Yan et al., 2010).  
Aberrant function of NF-κB is always observed in the inflammatory-
associated cancer as it can be activated by different stimuli such as inflammatory 
signals, hypoxia mediater, oncogenic proteins etc (Yan et al., 2010). Its activation in 
chronic inflammation can induce the expression of proinflammatory cytokines 
including tumor necrosis factor (TNF) α, interleukin (IL)-6 and -8, adhesion 
molecules, matrix metalloproteinases (MMP) -2 and -9, cyclooxygenase-2 (COX-2), 
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and inducible nitric oxide synthase (iNOS) (Lu et al., 2006; Sawhney et al., 2007; 
Ikebe et al., 2012). In OSCC, NF-κB was found to be highly expressed in betel quid-
associated oral submucous fibrosis (Tilakaratne et al., 2006) and radiation-induced 
oral mucositis (Ikebe et al., 2012). The activation of NF-κB is triggered by DNA 
damage and ROS formation in the oral cavity. Besides that, in vivo study of OSCC 
patient’s specimen concluded that NF-κB contributes to tumor invasion and OSCC 
hematologic and lymphatic metastases (Yan et al., 2010). Moreover, NF-κB is 
closely coordinated with other signaling pathways such as EGFR and WNT. 
Overexpression of EGFR in OSCC may upregulate its downstream signaling 
pathways. AKT can potentially upregulate NF-κB transactivation directly through 
phosphorylation of p65 domain (Magné et al., 2006), or indirectly by controlling IκB 
kinase (IKK) activity (Oeckinghaus et al., 2011). Aberrant function of NF-κB can 
also transactivate STAT3 by the release of IL-6 in the autocrine/paracrine 
mechanism (Squarize et al., 2006). IKKs can also transactivate MAPK in the NF-κB-
independent pathway. Furthermore, IKKs can also stabilize β-catenin by competing 
the distinct phosphorylation sites targeted by glycogen synthase kinase 3β (GSK3β), 
and induce cyclin D1 expression (Oeckinghaus et al., 2011).  Therefore, it is believed 
that NF-κB plays an important role in linking up inflammation and cancer together. 
 
2.1.4.4 HIF-1α signaling pathway  
Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor that is 
critically involved in oxygen homeostasis (Yan et al., 2014). It is made up of α and β 
subunits, whereby HIF-1α is the key mediator in oxygen regulation which contribute 
to HIF-1 activity (Li et al., 2012). In normoxia condition, HIF-1α is subject to 
oxygen-dependent hydroxylation and undergoes proteolytic degradation (Rodolico et 
